Roche Launches Two Cyclospora Testing Options

Dow Jones08-06

Roche said it launched two new testing options for labs to address the public health impact of the cyclospora parasite.

One test is for the specific detection of cyclospora only using hydrolysis probe chemistry and the other includes multiplex real-time detection of a variety of intestinal parasites.

The tests have been released in collaboration with subsidiary TIB MOLBIOL, a Berlin-based biotechnology company.

Cyclospora is a parasite that is linked to contaminated fresh imported produce, providing challenges for food safety and industrial supply chains.

Dan Malarek, president and chief executive of Roche Diagnostics North America, said Roche's testing infrastructure and scientific partnerships will allow it to provide solutions that help labs respond to evolving public health needs.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2657694653?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 23:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657694653","market":"fut","top_or_hot":-1,"title":"Roche Launches Two Cyclospora Testing Options","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Roche said it launched two new testing options for labs to address the public health impact of the cyclospora parasite. \n</p>\n<p>\n  One test is for the specific detection of cyclospora only using hydrolysis probe chemistry and the other includes multiplex real-time detection of a variety of intestinal parasites. \n</p>\n<p>\n  The tests have been released in collaboration with subsidiary TIB MOLBIOL, a Berlin-based biotechnology company. \n</p>\n<p>\n  Cyclospora is a parasite that is linked to contaminated fresh imported produce, providing challenges for food safety and industrial supply chains. \n</p>\n<p>\n  Dan Malarek, president and chief executive of Roche Diagnostics North America, said Roche's testing infrastructure and scientific partnerships will allow it to provide solutions that help labs respond to evolving public health needs. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roche Launches Two Cyclospora Testing Options</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoche Launches Two Cyclospora Testing Options\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-08-06 23:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Roche said it launched two new testing options for labs to address the public health impact of the cyclospora parasite. \n</p>\n<p>\n  One test is for the specific detection of cyclospora only using hydrolysis probe chemistry and the other includes multiplex real-time detection of a variety of intestinal parasites. \n</p>\n<p>\n  The tests have been released in collaboration with subsidiary TIB MOLBIOL, a Berlin-based biotechnology company. \n</p>\n<p>\n  Cyclospora is a parasite that is linked to contaminated fresh imported produce, providing challenges for food safety and industrial supply chains. \n</p>\n<p>\n  Dan Malarek, president and chief executive of Roche Diagnostics North America, said Roche's testing infrastructure and scientific partnerships will allow it to provide solutions that help labs respond to evolving public health needs. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HRTS","symbol_name":"Tema Heart & Health ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2657694653","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657694653","pubTimestamp":1786029840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Roche said it launched two new testing options for labs to address the public health impact of the cyclospora parasite.One test is for the specific detection of cyclospora only using hydrolysis probe chemistry and the other includes multiplex real-time detection of a variety of intestinal parasites.The tests have been released in collaboration with subsidiary TIB MOLBIOL, a Berlin-based biotechnology company.Cyclospora is a parasite that is linked to contaminated fresh imported produce, providing challenges for food safety and industrial supply chains.Dan Malarek, president and chief executive of Roche Diagnostics North America, said Roche's testing infrastructure and scientific partnerships will allow it to provide solutions that help labs respond to evolving public health needs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HRTS":"Tema Heart & Health ETF","CANC":"TEMA ONCOLOGY ETF","BK4007":"制药","03165":"华夏欧优股对冲","RHHBY":"罗氏控股"},"translate_title":"罗氏推出两种环孢菌检测方案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CANC":0.6,"RHHBY":0.9,"HRTS":0.6,"03165":0.6},"content_text":"Roche said it launched two new testing options for labs to address the public health impact of the cyclospora parasite. \n\n\n  One test is for the specific detection of cyclospora only using hydrolysis probe chemistry and the other includes multiplex real-time detection of a variety of intestinal parasites. \n\n\n  The tests have been released in collaboration with subsidiary TIB MOLBIOL, a Berlin-based biotechnology company. \n\n\n  Cyclospora is a parasite that is linked to contaminated fresh imported produce, providing challenges for food safety and industrial supply chains. \n\n\n  Dan Malarek, president and chief executive of Roche Diagnostics North America, said Roche's testing infrastructure and scientific partnerships will allow it to provide solutions that help labs respond to evolving public health needs.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2657694653","isCrawlerRequest":true}